Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:age |
children 12 months and older
|
| gptkbp:alternativeTo |
gptkb:MMR_II
|
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States |
| gptkbp:ATCCode |
gptkb:J07BD52
|
| gptkbp:broadcastOn |
two doses
|
| gptkbp:contains |
live attenuated measles virus
live attenuated mumps virus live attenuated rubella virus |
| https://www.w3.org/2000/01/rdf-schema#label |
Priorix
|
| gptkbp:indication |
measles prevention
mumps prevention rubella prevention |
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:pregnancyCategory |
contraindicated
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
fever
injection site reaction rash |
| gptkbp:storage |
2-8°C
|
| gptkbp:WHOPrequalified |
yes
|
| gptkbp:bfsParent |
gptkb:measles,_mumps,_rubella_vaccination
|
| gptkbp:bfsLayer |
8
|